Robert Landewé mostly deals with Internal medicine, Rheumatoid arthritis, Physical therapy, Ankylosing spondylitis and Surgery. His Internal medicine research incorporates themes from Gastroenterology and Placebo. The study incorporates disciplines such as Erythrocyte sedimentation rate, Connective tissue disease and Methotrexate in addition to Rheumatoid arthritis.
His Physical therapy research integrates issues from Clinical trial, Systematic review, Rheumatism, Evidence-based medicine and Severity of illness. His study looks at the relationship between Ankylosing spondylitis and fields such as Cohort, as well as how they intersect with chemical problems. His Surgery study incorporates themes from Odds ratio, Epidemiology, Combination therapy and Sulfasalazine.
His main research concerns Internal medicine, Physical therapy, Rheumatoid arthritis, Ankylosing spondylitis and In patient. Robert Landewé has researched Internal medicine in several fields, including Gastroenterology, Placebo and Surgery. His research investigates the connection between Physical therapy and topics such as Clinical trial that intersect with issues in Observational study.
Robert Landewé has included themes like Methotrexate, Disease, Combination therapy and Arthritis in his Rheumatoid arthritis study. His Ankylosing spondylitis study integrates concerns from other disciplines, such as BASFI, BASDAI and Radiography. The Rheumatology study combines topics in areas such as Severity of illness and Etanercept.
Robert Landewé focuses on Internal medicine, Axial spondyloarthritis, In patient, Ankylosing spondylitis and Cohort. His study ties his expertise on Placebo together with the subject of Internal medicine. Robert Landewé combines subjects such as Family medicine, Certolizumab pegol and Radiography with his study of Axial spondyloarthritis.
His work carried out in the field of Ankylosing spondylitis brings together such families of science as Randomized controlled trial, BASDAI, Severity of illness and Confounding. His Cohort research includes themes of Sacroiliitis, Disease, Generalized estimating equation, Back pain and Physical therapy. His Rheumatoid arthritis study combines topics in areas such as Clinical trial, Intensive care medicine and Arthritis.
Robert Landewé spends much of his time researching Internal medicine, Ankylosing spondylitis, Axial spondyloarthritis, Rheumatoid arthritis and In patient. His Internal medicine research is multidisciplinary, incorporating elements of Placebo and Radiography. His study in Ankylosing spondylitis is interdisciplinary in nature, drawing from both Adalimumab, Severity of illness, Confounding and Clinical trial.
His Axial spondyloarthritis study combines topics from a wide range of disciplines, such as Latent transition analysis, Physical therapy, Magnetic resonance imaging and Class. His study focuses on the intersection of Physical therapy and fields such as Outcomes research with connections in the field of Absenteeism. He interconnects Disease activity, Methotrexate, Incidence and Arthritis in the investigation of issues within Rheumatoid arthritis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch.
Annals of the Rheumatic Diseases (2014)
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
M Rudwaleit;D van der Heijde;R Landewé;J Listing.
Annals of the Rheumatic Diseases (2009)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados.
Revmatologiia (2011)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados.
Annals of the Rheumatic Diseases (2010)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang.
Arthritis & Rheumatism (2011)
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
J. Sieper;M. Rudwaleit;X. Baraliakos;J. Brandt.
Annals of the Rheumatic Diseases (2009)
Dickkopf-1 is a master regulator of joint remodeling
Danielle Diarra;Marina Stolina;Karin Polzer;Jochen Zwerina.
Nature Medicine (2007)
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
M. Rudwaleit;D.M.F.M. van der Heijde;R.B.M. Landewé;N. Akkoc.
Annals of the Rheumatic Diseases (2011)
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk.
Annals of the Rheumatic Diseases (2016)
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Bernard Combe;Robert Landewé;Cedric Lukas;Horatio D Bolosiu.
Annals of the Rheumatic Diseases (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Leiden University Medical Center
Hôpital Cochin
University of Alberta
University of Leeds
Vrije Universiteit Amsterdam
Medical University of Vienna
University of Washington
Sorbonne University
Charité - University Medicine Berlin
Medical University of Vienna
University of California, Riverside
Huawei Technologies (China)
Virginia Tech
Chinese Academy of Sciences
Siemens (Germany)
University of Science and Technology Beijing
University of Science and Technology of China
North Carolina State University
National Institutes of Health
University of Washington
BC Cancer Research Centre
Sapienza University of Rome
University of California, Berkeley
Mayo Clinic
Baruch College
University of Pennsylvania